David C M Kong
Overview
Explore the profile of David C M Kong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
1381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urbancic K, Kong D, Johnson P, Yong M, Slavin M, Thursky K
Intern Med J
. 2024 Dec;
55(2):223-232.
PMID: 39617970
Background: Antimicrobial stewardship (AMS) guidelines now recommend antifungal stewardship (AFS) interventions to improve the management of invasive fungal diseases (IFDs). AFS programmes have not been reported in Australia. Aims: To...
2.
Neoh C, Jeong W, Kong D, Beardsley J, Kwok P, Slavin M, et al.
Expert Rev Anti Infect Ther
. 2024 Sep;
22(12):1085-1098.
PMID: 39317940
Introduction: The rising prevalence of difficult-to-treat, deep-seated invasive fungal diseases (IFD) has led to high mortality. Currently available antifungal treatments, administered predominantly orally or intravenously, may not sufficiently penetrate certain...
3.
Lim A, Khumra S, Dalley A, Bubb G, Chien J, Kong D
Int J Pharm Pract
. 2024 Apr;
32(4):267-273.
PMID: 38676911
Objectives: Incorrect labelling of a penicillin allergy can lead to unnecessary use of broad-spectrum, less effective, more harmful, or more costly antibiotics. Community pharmacists are well positioned to educate the...
4.
Neoh C, Chen S, Lanternier F, Tio S, Halliday C, Kidd S, et al.
Clin Microbiol Rev
. 2024 Mar;
37(2):e0000423.
PMID: 38551323
SUMMARYAlthough species and are uncommon causes of invasive fungal diseases (IFDs), these infections are associated with high mortality and are costly to treat with a limited armamentarium of antifungal drugs....
5.
Neoh C, Chen S, Kong D, Hamilton K, Nguyen Q, Spelman T, et al.
J Antimicrob Chemother
. 2023 Nov;
79(1):46-54.
PMID: 37944018
Background: Little is known about the short- and long-term healthcare costs of invasive Scedosporium/Lomentospora prolificans infections, particularly in patient groups without haematological malignancy. This study investigated excess index hospitalization costs...
6.
Neoh C, Chen S, Crowe A, Hamilton K, Nguyen Q, Marriott D, et al.
Open Forum Infect Dis
. 2023 Mar;
10(2):ofad059.
PMID: 36861090
Background: Management of infections remains challenging. We described predisposing factors, clinical manifestations, and outcomes of these rare mold infections, including predictors of early (1-month) and late (18-month) all-cause mortality and...
7.
Lindsay J, Walti C, Halpern A, Xie H, Chung E, Schonhoff K, et al.
Blood Adv
. 2023 Feb;
7(13):3140-3145.
PMID: 36790925
No abstract available.
8.
Landersdorfer C, Lee W, Nation R, Kong D, Buising K, Peel T, et al.
Mol Pharm
. 2022 Dec;
20(3):1509-1518.
PMID: 36512679
Arthroplasty is a healthcare priority and represents high volume, high cost surgery. Periprosthetic joint infection (PJI) results in significant mortality, thus it is vital that the risk for PJI is...
9.
Saha S, Thursky K, Kong D, Mazza D
Antibiotics (Basel)
. 2022 Sep;
11(9).
PMID: 36139938
Interprofessional collaboration between general practitioners (GPs) and community pharmacists (CPs) is central to implement antimicrobial stewardship (AMS) programmes in primary care. This study aimed to design a GP/pharmacist antimicrobial stewardship...
10.
Pathadka S, Yan V, Neoh C, Al-Badriyeh D, Kong D, Slavin M, et al.
Drugs
. 2022 Aug;
82(11):1193-1205.
PMID: 35960433
Background: Understanding the trend of global antifungal agent consumption could assist with identification of global healthcare policy inadequacies and promote accessibility and availability of antifungal agents. Methods: Using pharmaceutical sales...